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The proposed study has one central purpose, to determine if the Comprehensive     
System (CS), an empirically valid system for scoring and interpreting the Rorschach 
Inkblot Test, can effectively discriminate between individuals diagnosed with borderline 
personality disorder (BPD) and those diagnosed with bipolar disorder. Previously 
conducted, peer-reviewed studies since 1985 have uncovered CS variables that were 
statistically significant in BPD and in bipolar groups when examined separately. 
However, there have been relatively few such investigations, making the body of research 
with CS variables small in this area. It would be valuable to know whether or not the CS 
is a useful tool in distinguishing between these two disorders. A second goal of the 
current study is to uncover variables that help diagnose both bipolar disorder and BPD as 
separate entities. Some CS variables have not been previously studied with regard bipolar 
disorder or BPD. Additional research with variables known to be useful in identifying 
iv  
these disorders will cross-validate findings that already exist. Moreover, if the Rorschach 
could help classify individuals with these disorders and uncover distinct differences 
between them in their test results, these data would also lend support for the idea that 
these are indeed two different disorders, a tertiary goal of the current study. 
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Chapter 1:  Introduction 
Borderline Personality Disorder (BPD) and bipolar disorder are illnesses that 
cause significant functional impairment, are expensive to treat, are costly in terms of lost 
productivity, are associated with high comorbidity rates, and frequently co-occur with 
each other. Because individuals diagnosed with either disorder commonly demonstrate 
impulsivity, affective instability, destructive behaviors including alcohol and drug use, 
sexual acting out, parasuicidal behavior, and suicidal attempts, there is debate in the 
literature as to whether they are each distinct diagnostic categories or if they are actually 
different labels for the same problem.  
Moreover, several studies have shown that BPD is one of the most frequently 
occurring Axis II disorder in patients diagnosed with a disorder on the bipolar spectrum 
(Brieger, Ehrt, and Marneros, 2003; Üçok, Karaveli, Kundakçi, and Yazici, 1998; 
Benazzi, 2000). And, data is mounting that indicate that BPD and Bipolar I Disorder 
occur together more frequently than BPD does with most other psychiatric diagnoses.  
Moreover, on a separate but related front, researcher conceptualizations about the bipolar 
spectrum are broadening (Akiskal, 1996; Hirschfeld, 2001; Deltito et al, 2001). Some are 
beginning to question the legitimacy of the BPD diagnosis. These researchers suggest 
that a bipolar disturbance is often misdiagnosed as BPD because the root of marital 
discord, promiscuity, poor work performance, and/or substance abuse is often attributed 
to a personality disorder, rather then complications of a mood disturbance. Others, 
however, disagree and, for example, have demonstrated through confirmatory analysis 
that both a one factor model and a three factor model that provide empirical support the 
existence of BPD. (Zanarini et al., 1998; Sanislow et al. (2002). 
The Rorschach Inkblot Test is a perceptual-cognitive task in which the respondent 
must organize a response to an ambiguous stimulus. The manner in which an individual 
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approaches this task is thought to be similar to how he/she responds to ambiguity in daily 
life. The end result of this activity provides valuable information about how individuals 
people focus their attention, perceive people and events, reflect on their experience, 
manage emotions and stress, and view themselves and others. Since its introduction to the 
professional public in September 1921, several different systems have been created to 
administer, score, and interpret the instrument, each of which contained elements that 
threatened its credibility (Exner, 2003). Beginning in 1970 with a series of surveys to 
help define the existing problems with the instrument, John Exner sought to develop a 
new system that would retain the parts of the previous systems that worked well, discard 
the elements that were flawed, and add new variables where opportunities existed. The 
method he developed, the Comprehensive System (CS), was the result of his efforts and 
was introduced in 1974. Since then, the body of empirical knowledge about the CS 
continues to be refined, continually improving the already respectable intercoder 
agreement, retest reliability, validity, and normative samples.  
The CS has endured multiple criticisms on multiple fronts. For example, 
Nezworski and Wood questioned the validation data used to generate interpretations 
about egocentricity (1995). Wood, Nezworski, and Stejkal raised questions about 
interrater agreement findings as well as the validation data underlying several of the CS’s 
indices (1996). They further questioned the integrity of studies reported in various 
editions of the basic CS textbook for not having been also published in peer-reviewed 
journal articles. In another example, Hunsley and Bailey conducted a review of the 
Rorschach literature and concluded that there was little scientific evidence to support the 
clinical utility of the Rorschach and that even if it could provide valid information about 
personality structure, no replicated evidence existed to support that it would have any 
meaningful bearing on services or treatment outcome (1999). 
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Despite criticism of the CS’s psychometric properties, the Rorschach has been 
consistently shown to demonstrate ICCs of greater than .90 for the majority of its 
variables. In adults, the short- and long-term stability of most CS variables exceeds .75, 
and 19 of its core variables have demonstrated one-year or three-year retest correlations 
of .85 or higher (Weiner, 1999; Meyer et al., 2002). In children its variables have been 
shown to move along a developmental trajectory that maps onto cognitive and emotional 
theories of development. And, meta-analysis of MMPI and Rorschach protocols suggests 
that these instruments possess similar mean validity coefficients, both of which are 
among the highest ranking of all psychological assessment tools. In addition, the 
Rorschach CS includes normative reference data on 600 nonpatient adults, 1390 children 
ages 5 to 16, and several patient groups. And, in response to criticism, a new reference 
sample was recently gathered that revealed that the norms have changed little in the past 
two decades. 
In terms of its utility, the Rorschach can be helpful in assessing patients who 
conceal psychopathology or who are attempting to feign more distress than is true. It has 
been demonstrated to be effective at identifying psychosis and provides a valuable 
description of an individual’s personality traits that can illuminate problems that may 
become obstacles to successful treatment. And, it can inform treatment planning by 
helping define treatment goals (Bihlar & Carlson, 2000). The Rorschach can also be a 
useful tool in monitoring treatment progress and improvement over time (Weiner & 
Exner, 1991). 
Relatively few studies in the past 25 years have been conducted analyzing CS 
variables that examine the Rorschach’s ability to identify either bipolar disorder or BPD. 
Moreover, no studies exist that have attempted to ascertain whether the CS can 
discriminate between them. Of the few studies that do exist, BPD has been associated in 
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the CS with lack of a differentiated coping style, chronic stimulus overload, ego-dystonic 
aggression, and egocentricity (Exner, 1986) and possibly the presence of trauma in the 
protocol (Mihura, 2006). The protocols of manic bipolar patients have been significant 
for distortions of reality associated with anger and hostility, an elevated Perceptual 
Thinking Index, and severe instances in the protocol of ideational impulsivity and 
disjointed cognition (Singer & Brabender, 1993). And, depressed bipolar patients have 
been shown to be less able to produce well-organized and sophisticated percepts than 
their manic counterparts. While it is unlikely that the Rorschach will be able to 
definitively place an individual into a distinct diagnostic category, any additional 
assistance that an assessment instrument could scientifically provide would be potentially 
helpful. Furthermore, if the Rorschach were able to be able to discriminate between these 
two groups, it would also provide additional support for the idea that BPD and bipolar 
disorder are distinct diagnostic entities.   
The current study has one central purpose, to determine whether or not the CS for 
the Rorschach Inkblot Test can effectively discriminate between individuals diagnosed 
with BPD and those diagnosed with bipolar disorder. Previously conducted, peer-
reviewed studies since 1985 have uncovered CS variables that were statistically 
significant in BPD and in bipolar groups when examined separately. However, there have 
been relatively few such investigations, making the body of research with CS variables 
small in this area. It would be valuable to know whether or not the CS is a useful tool in 
making diagnostic determinations for these two disorders, especially given the previously 
discussed criticisms of the instrument. A second goal of the current study is to uncover 
variables that help diagnose both bipolar disorder and BPD. Some of these variables have 
not been previously studied with regard bipolar disorder or BPD. Others may cross-
validate findings that already exist. Moreover, if the Rorschach could help classify 
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individuals with these disorders and uncover distinct differences between them in their 
test results, these data would also lend support for the idea that these are indeed two 






















Chapter 2: Review of the Literature 
 A psychological test is a collection of questions or stimuli to which an 
individual is to for the purpose of understanding their symptoms, personality 
characteristics, or traits (Kaplan and Saccuzzo, 2008). These can provide information 
about cognitive, emotional, behavioral, or interpersonal functioning or some combination 
thereof. Some personality tests seek to describe the structure and features of an 
individual’s personality, while others are intended to evaluate the presence of signs and 
symptoms of psychopathology or psychiatric disorders. These instruments can be further 
divided into two types of tests:  objective tests and projective tests. Objective tests 
generally include standardized questions in which the answers are restricted to a limited 
choice of answers. Included among objective tests are structured and semi-structured 
interviews, as they are designed to illicit specific responses to specific questions that are 
standardized, presented in a particular order, and coded in a standardized manner. 
Projective tests have traditionally involved presenting to the examinee novel or 
ambiguous stimuli and have permitted an open-ended response format, allowing for an 
almost unlimited number of different responses (Compas & Gotlib, 2002). This format 
was purposely devised so as to provide minimal structure with the idea that the internal 
dynamics of the examinee are more likely to reveal themselves under these conditions. 
Stimuli of this kind commonly includes inkblots, ambiguously drawn pictures, drawings 
made by the examinee, and incomplete sentences. Frank proposed that projective 
techniques were psychological r-rays (1948). It was postulated that in the process of 
formulating a response, examinees were thought to project aspects of their personality 
onto the stimuli in an effort to describe or make sense of them. This notion was based 
upon Freud’s concept of projection, the idea that people unconsciously attribute their own 
negative impulses and personality traits onto others. Under this model,  projective tests 
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then were hypothesized to bypass conscious defenses in responding and allow test 
examiners access to psychological processes of which the respondent was unaware. 
Because projective measures are believed to elicit unconscious material, they are believed 
by some to provide incremental validity beyond what objective measures offer (Weiner, 
1999).   
THE RORSCHACH INKBLOT TEST 
The Rorschach Inkblot Test is often considered to be the quintessential projective 
personality measure. And, in its first several decades of existence, it was approached 
from a psychoanalytic point of view as a “stimulus-to-fantasy” task (Erdberg, 1990). The 
examinee symbolically projected her/her inner need states onto an ambiguous blot of ink 
that the administrator would then interpret. Although vestiges of the psychoanalytic 
approach remain today, the prevailing current approach to the Rorschach is one that treats 
it more as a perceptual-cognitive task in which the respondent must organize a response 
to an ambiguous stimulus. While there is certainly ample ambiguity in each blot, each 
card is designed in such a manner that correct and incorrect answers do exist for each 
inkblot. The manner in which the test-taker approaches this task is thought to be similar 
to the way in which he/she responds to ambiguity in daily life. And, the content is more 
secondary to the structural and perceptual aspects of the response. Current Rorschach 
assessment and interpretation provides dependable information about the manner in 
which people focus their attention, perceive people and events, reflect on their 
experience, manage emotions, handle stress, and view themselves and others. Rorschach 
responses can also provide information to underlying needs, attitudes, conflicts, and 
concerns that likely influence behavior, all or some of which can be beyond conscious 




Data regarding the CS’s Rorschach indices has been consistently positive across 
numerous studies, whether measured by percentage agreement or by kappa and intraclass 
correlation coefficients (ICC). Meyer and colleagues (2002), using four different 
samples, 219 protocols, and 4,761 responses, found a median ICC of .93 for intercoder 
agreement across 138 Rorschach variables, with the ICC’s for134 of them variables 
falling in the excellent range. Viglione and Taylor (2003), examined coder agreement for 
84 protocols and 1,732 responses and found a median ICC of .92 for 68 variables 
considered to be of central interpretive significance in the CS. Some critics of the 
Rorschach have nevertheless asserted that codes were originally included in the CS solely 
on the basis of the percentage of intercoder agreement (80% or more) and that no 
intercoder agreement data exists to suggest that clinicians in practice using the instrument 
are coding reliably (Lilienfeld, Wood, & Garb, 2000). The kappa and ICC data 
mentioned previously render the first of these two arguments moot. The second concern 
holds the Rorschach CS to a level of scientific rigor not applied to other instruments. 
Field studies of intercoder agreement are not required in the literature to prove the 
psychometric adequacy of other assessment instruments. For example, no studies exist 
reporting interrater agreement for scoring Wechsler Comprehension items. Furthermore, 
the responsibility for competence administering, coding, and interpreting psychological 
instruments lies with the practitioner who uses a test, not with the instrument itself.   
Reliability 
Reliability studies with both children and adults over periods of time ranging from 
7 days to 3 years have demonstrated sound reliability estimates for most Rorschach 
variables, including summary scores and indices that are believed to reflect trait-like 
characteristics (Weiner, 1999). This includes the majority of CS variables. In adults, the 
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short- and long-term stability of most CS variables exceeds .75.  In addition, 19 core 
variables with major interpretive significance have demonstrated one-year or three-year 
retest correlations of .85 or higher. Two exceptions appear to emerge in the research data. 
First, Rorschach summary scores that are composed few variables seem to not produce as 
desirable retest correlations. And, as would be expected, combinations of CS variables 
that are believed to measure situational state characteristics do not produce good 
reliability estimates either. The results for children reveal stability coefficients similar to 
those of adults when retested over brief intervals. Over a 2-year period, indices for 
children and adolescents  initially fluctuate markedly but then demonstrate steady 
increasing long-term consistency as they grow older. This pattern of results in younger 
examinees mirrors the gradual consolidation of personality characteristics during the 
developmental years as people age.   
Rorschach critics have argued that the reliability of the Rorschach is yet to be 
demonstrated because only a portion of the CS variables have been included in reports of 
retest studies (Lilienfeld et al., 2000). Rorschach proponents contend that the majority of 
the retest correlations described as missing are either: a.) composite variables for which 
good reliability data exists for each of their component parts; or b.) variables that only 
occur very infrequently so as not to prevent meaningful statistical analysis. Moreover, 
proponents also assert that some variables are more critical to the interpretation than 
others. And, key CS interpretive variables demonstrate particularly high retest 
correlations. Viglione and Hilsenroth (2001) have published an extensive summary of the 
Rorschach reliability data that contains, either individually or in combination, nearly all 
of the CS variables. The retest correlations for all commonly occurring CS variables that 
are important to the interpretation of trait dimensions of personality compare favorably 
with the reliability statistics for other frequently used and psychometrically sound 
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assessment tools, including the Wechsler Scales and the Minnesota Multiphasic 
Personality Inventory. It is also important to note that Rorschach critics have not 
published any original data contradicting the  strong reliability research for the regularly 
occurring Rorschach indices of trait variables. In addition, the retest data for children 
contains evidence of construct validity for Rorschach variables. There is an increasing 
two-year stability of Rorschach findings as children age. For example, the Egocentricity 
Index, which is believed to be a measure of self-focusing or self-centeredness à la Jean 
Piaget shows an almost perfectly linear decrease in young people from age 5 to 16, a 
finding that is highly consistent with theory and data in developmental psychology. 
Similarly, the ratio of Form-Color to Color-Form responses, believed to relate to mature 
affective modulation and to immature affective modulation, respectively, gradually shifts 
from color-dominated to form-dominated as children move into adolescence, which is 
consistent with what is known about emotional maturation across childhood (Exner, 
2003). 
Validity 
Although critics have contended in the literature that the Rorschach has little 
criterion or construct validity (Dawes, 1994; Hunsely & Bailey, 1999; Lilienfeld, Wood, 
& Garb, 2000), several meta-analytic studies have been published demonstrating strong 
Rorschach validity (Atkinson, Quarrington, Alp, & Cyr, 1986; Hiller, Rosenthal, 
Bornstein, Berry, & Brunell-Neuleib, 1999; Parker, Hanson & Hunsley, 1988). Hiller, 
Rosenthal, Bornstein, Berry, and Brunell-Neuleib (1999) conducted a meta-analysis 
based on a random sample of Rorschach and MMPI research studies published from 1977 
to 1997. Their analysis of 2,276 Rorschach protocols and 5,007 MMPI protocols found 
almost identical validity for the Rorschach and the MMPI, with a mean validity 
coefficient of .29 for Rorschach variables and .30 for MMPI variables. The investigators 
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concluded that the validity for both instruments “is about as good as can be expected for 
personality tests” (Hiller et al.,1999). They noted that each instrument had strengths 
relative to the other. The MMPI correlated more highly than the Rorschach with 
psychiatric diagnosis and self-reports with average effect sizes of .37 and .18, 
respectively. The Rorschach variables demonstrated an increased ability over the MMPI 
variables in predicting behavioral outcomes, such as whether patients continue in or drop 
out of treatment. In addition, 1997 study conducted by Meyer concluded that the 
Rorschach CS and MMPI correlate remarkable well when people respond to both 
instruments in either an open or in a guarded manner, as opposed to being forthcoming on 
one and defensive on either or both (Meyer, 1997). In a more recent investigation also 
conducted by Meyer et al. (2001), the research team reviewed predictive and meta-
analytic studies of various psychological tests and compared their results to those of 
medical tests. The authors found that validity coefficients for psychological tests, which 
fell in the .30 to .50 range, including the Rorschach and MMPI-2, were comparable to 
those of many medical tests, such as electrocardiograms, mammography, and magnetic 
resonance imaging.   
In addition to providing the aforementioned construct validity related to 
maturational changes in the expected direction, the CS normative sample also provided 
additional construct validity. The adult reference sample includes 600 nonpatients and 
535 psychiatric outpatients.  In addition,  there 279 inpatients with major depressive 
disorder as well as 328 patients hospitalized with a first admission for schizophrenia 
(Exner, 2003). Generally speaking, these four groups can be expected to form a 
continuum of increasingly severe psychiatric disturbance. Consistent with this notion, 
Rorschach indices of impaired reality testing and disordered thinking increase linearly 
across these groups, thus supporting them as measures of disturbance. The mean X-% 
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ranges from .07 in nonpatients to .16 in outpatients, to .20 in depressed inpatients, and to 
.37 in schizophrenic inpatients. The mean WSum6 for these four groups, respectively, are 
4.48, 9.36, 18.36, and 42.17 (Exner, 2003).   
Normative Sample 
As previously described, the Rorschach CS includes normative reference data on 
600 nonpatient adults, 1390 children ages 5 to 16, and several patient groups. Because the 
adult nonpatient sample was collected predominately between 1974 and 1986, there has 
been concern from critics that the data may be outdated and in need of revision. Before 
his death, Exner undertook a new normative study in which nonpatient adults were 
administered tests across the country by experienced examiners (2003). With some minor 
differences leading to only minimal interpretive significance, the new reference group 
data set is markedly similar to the older one. As a result,  no noteworthy modifications in 
interpretive strategy have emerged. Critics of the Rorschach CS alleged that it is overly 
pathologizing because it purportedly identifies people as psychologically disturbed when 
they are not (Wood, Nezworski, Garb, & Lilienfeld, 2001). This allegation is based in 
part on a normative study conducted in northern California that identified differences 
from the CS reference data in frequency of pathological indicators. However, the sample 
size in this investigation was relatively small by comparison to Exner’s, only 123 
participants, was demographically an unrepresentative sample, and used inexperienced 
examiners to collect the data (Meyer, 2001). The allegation of overpathologizing is 
additionally based on control sample data, collected from 32 diverse studies. These data 
also differ from the CS nonpatient population and do not qualify as representative 
samples of nonpatient adults. Furthermore, of the 32 individuals sampled, 16 were 
college students or elderly individuals, both of which commonly produce atypical test 
responses when serving as volunteer participants in research studies, further indicting that 
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the sample is not representative of the population. Moreover, five of the protocols were 
from individuals who were either current or former psychiatric patients, and 11 others 
were recruited without any mental health screening, leaving their histories largely 
unknown. 
Utility of the Rorschach 
The Rorschach is frequently used by clinicians in outpatient, inpatient, 
organizational, and forensic settings, and can be helpful in several different applications 
(Ganellen, 2004). For example, the Rorschach may be especially useful in assessing 
patients who are either attempting to conceal psychopathology or who are attempting to 
positively malinger (Ganellen, 1994; Ganellen, Wasyliw, Haywood, & Grossman, 1996; 
Grossman, Wasyliw, Benn, & Gyoerkoe, 2002). Although the Rorschach is not a test that 
can alone yield a diagnosis and should not be used as the only test instrument on which to 
base a diagnosis, Rorschach indices can reveal aspects of functioning that have been 
empirically demonstrated to be correlated to particular disorders. For example, Rorschach 
indices of a thought disorder and impaired reality testing can be useful in identifying 
schizophrenia or in confirming the presence of a psychotic disorder. Variables related to 
dysphoric mood and indications of pessimistic thinking assist in identifying depression. 
Indices related to coping, subjectively experienced distress, and stimulus overload can 
help identify an anxiety disorder. In addition, the Rorschach can provide valuable 
information to help inform treatment planning by describing personality traits that will 
effect the therapeutic process (Elfhag, Rossner, Lindgren, Anderson, & Carlsson, 2004; 
Stokes et al., 2003). For example, knowing that an individual is prone to shame, which is 
identified by use of dimensionalized shading in the record, can alert the clinician to help 
address this concern sooner rather than later so as to thwart a possible treatment failure. 
The Rorschach can also help describe problems in several domains of functioning (such 
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as such as affect modulation problems) that can help define therapy goals (Bihlar & 
Carlson, 2000, 2001). Furthermore, the CS can also assist practitioners to understand 
particular styles of coping that may be obstacles to treatment (such as over-reliance on 
fantasy or intellectualization) (Ackerman, Hilsenroth, Clemence, Weatherill, & Fowler, 
2000; Colson, Eyman, & Coyne, 1994; Hilsenroth, Handler, Toman, & Padawer, 1995; 
Meyer, 2000; Meyer & Handler, 1997; Nygren, 2004; Weiner, 1999; 2004). Finally, the 
Rorschach is an effective means of documenting progress in treatment and improvement 
in functioning over time (Abraham, Lepisto, Lewis, Schultz, & Finkelberg, 1994; Blat & 
Ford, 1994; Exner & Andronikof-Sanglade, 1992; Fowler et al, 2004; Gronnerod, 2004; 
Weiner & Exner, 1991).   
Limitations of the Rorschach    
At the beginning of the current decade, debate sparked in the research literature 
about the Rorschach’s usefulness or lack thereof in answering diagnostic questions. Each 
article criticizing it was soon matched by a rebuttal. Although a full review of the 
criticisms and strengths of the Rorschach and the CS is beyond the scope of this review, 
two examples that highlight some of the CS’s limitations are presented here. For 
example, although the CS for the Rorschach has demonstrated itself to possess adequate 
psychometric characteristics and to be clinical useful, examination of the criticisms 
suggests that it possesses some limitations. Critics believe the data indicate that particular 
indices have limited or poor ability to detect some DSM-IV-TR diagnoses. Jorgensen, 
Andersen, & Dam (2000) found little evidence to suggest that the Depression Index 
(DEPI) could reliably predict a DSM-IV diagnosis of depression in either children or 
adults. While there appears to be little evidence supporting the use of the DEPI to assess 
current depression, a study conducted by Hartman, Wang, Berg, & Saether found that 
other Rorschach indices was able to identify cognitive and aggressive disturbances in 
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individuals who were actively depressed but not in individuals who have been previously 
depressed or in individuals who had never been depressed (2003). Also, the Rorschach 
could identify affective and coping disturbances in depressed individuals and to some 
degree in previously depressed individuals but not in individuals who had never 
experienced a major depressive episode.   
Another CS variable that has undergone scrutiny from Rorschach critics is the 
Suicide Constellation (S-Con), for its inability to predict individuals who attempt or will 
attempt suicide.  The empirical data on this variable are mixed at best. Exner and Wylie 
initially reported that the S-Con was able to correctly identify 75% of the suicide patients 
and 100% of the nonpatients (1977). These findings were later replicated in a cross-
validation study with the exact same results (Exner, 1986). However, another cross-
validation study conducted by Eyman and Eyman (1992) found markedly different 
results. Only 1 of 50 patients who had committed suicide had an S-Con score of 8 or 
higher. It should be noted that the methodology employed in this study raises questions 
about the generalizeability of these findings. These investigators followed the CS 
guidelines to score their protocols but instead used the system outlined by Rapaport, Gill, 
and Schafer (1946) to administer the test. Ordinarily, a comparison between two 
Rorschach studies with different administration methods could be easily overlooked, but 
the investigators concluded that the discrepancy between their results for the S-Con and 
the previously documented ones were so large that they could not be accounted for solely 
by a difference in test administration. Moreover, the S-Con could not differentiate 
between those that attempted suicide and those who did not in either adolescent (Silberg 
& Armstrong, 1992) or in adult (Meyer, 1993) inpatient samples,  although some of the 
variables that comprise the S-Con have been related to suicidal behavior (Arffa, 1982; 
Kendra, 1979; Silberg & Armstrong, 1992).   
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Rorschach advocates have responded to diagnostic and other criticisms of the 
instrument by explaining that Rorschach findings will likely not consistently correlate 
with the DSM in that it was not created to do so. According to Weiner, Spielberger, and 
Abeles (2002), the Rorschach Inkblot Method  
is not a diagnostic test.  It is a measure of personality processes.  To the extent 
that it measures disordered thinking, which it does very well, it assists in detecting 
schizophrenic disorder.  To the extent that it measures dysphoric mood and 
negative cognitions, which it does very well, it assists in identifying 
depression….However, it is not intended to serve as a sole criterion for 
diagnosing schizophrenic, mood, or anxiety-related disorders (p. 10).   
Although the Rorschach should not be used as a diagnostic tool, specific variables 
can provide valuable information about the presence of thoughts, feelings, and behaviors 
that are associated with particular diagnoses and in order to clarify diagnoses (Weiner, 
2004). To the extent that it can accurately and reliably perform such a task and with the 
assistance of other psychometrically sound instruments, practitioners can precisely 
understand the particular issues with which patients present and arrive at a diagnoses that 
best encompasses her/her unique characteristics. Self-report measures such as objective 
tests and clinical interviews can provide inaccurate information and be misleading 
(Huprich and Ganellen, 2006). Sometimes such inaccuracies are a result of deliberate 
misrepresentations of oneself so as to appear more disturbed or less disturbed depending 
on the patient’s goal. In other cases, individuals do not wish to acknowledge to 
themselves the existence of certain traits or characteristics because doing so would mean 
having to face certain difficult truths that they may not be emotional capable of 
managing. Also, individuals may misreport information about themselves simply because 
their ability to engage in introspective behaviors is not well-developed or because of a 
lack of awareness of how others view their behavior. The Rorschach, on the other hand, 
can provide information about an individual that may or may not be know to him/her or 
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that he/she may not wish to acknowledge or admit. As the CS has evolved, data have 
accumulated that illuminate associations between Rorschach variables and behavioral 
patterns, traits, and personality characteristics that may or may not be uncovered by self-
report. The more empirical evidence that mounts that describes clear associations 
between certain patterns of thinking, reacting, and behaving to DSM diagnoses, the more 
useful the instrument will become. 
 One hurdle for the Rorschach and the CS to overcome in the effort to help 
discriminate between disorders is to provide more empirical support that it can effectively 
perform this task. For example, Wood, Lilienfield Garb, and Nezworski point out that 
deviant verbalizations and poor form quality are associated with Schizophrenia, Bipolar 
Disorder, Borderline Personality Disorder, and Schizotypal Personality Disorder (2000). 
While this information does narrow the diagnostic possibilities substantially, if finer 
discriminations based on well-designed studies could be made between diagnostic 
categories, it would become an even more valuable part of a psychological assessment. 
To this end, more studies examining the potential differences among CS variables need to 
be undertaken. Two other disorders that share several common clinical features are 
bipolar disorder and BPD. Common to both of these problems is mood variability, 
impulsivity, suicidality, self-destructive behaviors, and substance abuse, among others. 
Because these diagnoses can be difficult at times to distinguish, psychological 
instruments that can provide information to assist in making this distinction would be 
valuable. To date, no studies exist that compare and contrast borderline personality 
disorder and bipolar disorder.  
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BORDERLINE PERSONALITY DISORDER 
The Diagnostic and Statistical Manual, Fourth Edition, Text Revision (DSM-IV-
TR; American Psychiatric Association, 2000, p. 710) characterizes Borderline Personality 
Disorder (BPD) as: 
A. A pervasive pattern of instability of interpersonal relationships, self-
image, and affects, and marked impulsivity beginning by early adulthood 
and present in a variety of contexts, as indicated by five (or more) of the 
following: 
B. frantic efforts to avoid real or imagined abandonment.   
C. a pattern of unstable and intense interpersonal relationships characterized 
by alternating between extremes of idealization and devaluation. 
D. identity disturbance: markedly and persistently unstable self-image or 
sense of self.  
E. impulsivity in at least two areas that are potentially self-damaging (e.g., 
spending, sex, substance abuse, reckless driving, binge eating). Note: Do 
not include suicidal or self-mutilating behavior covered in Criterion 5. 
F. recurrent suicidal behavior, gestures, or threats, or self-mutilating 
behavior. 
G. affective instability due to a marked reactivity of mood (e.g., intense 
episodic dysphoria, irritability, or anxiety usually lasting a few hours and 
only rarely more than a few days). 
H. chronic feelings of emptiness. 
I. inappropriate, intense anger or difficulty controlling anger (e.g., frequent 
displays of temper, constant anger, recurrent physical fights). 
J. transient, stress-related paranoid ideation or severe dissociative symptoms. 
BPD has sparked controversy as a diagnosis, in part, because women are much 
more frequently diagnosed with the disorder than are men (DSM-IV-TR, 2000). It has 
also received criticism for its apparent elasticity and frequent overlap with other 
diagnoses, especially mood disorders and other Cluster B personality disorders (Akiskal, 
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et al., 1985; Becker, 1997). Despite these drawbacks, researchers and practitioners 
continue to hold BPD as a useful framework for understanding and treating patient 
distress, and extensive research has focused on defining and describing BPD with greater 
clarity and accuracy (Millon, 1987; Stone, 1990; Tramantano, Javier, & Colon, 2003).  
Even though the DSM’s approach to the classification of BPD has been 
atheoretical (APA, 2001), many theoreticians have sought to describe its etiology. The 
term “borderline” was instituted in 1938 by Adolph Stern, a psychoanalyst, to describe 
individuals who were more disturbed than patients with neurotic organizations but who 
were not psychotic. They were believed to alternate between a neurosis and a psychosis 
(Stern, 1938), depending on their stress level. While this definition was eventually 
replaced by conceptualizations that emphasized oscillations in ego states, the term 
“borderline” continues to be used to describe patients who can function effectively in 
well-structured situations but who become destabilized and sometimes psychotic in the 
face of ambiguity, emotional uncertainty, or stress (Horwitz, et al. 1996). BPD began 
receiving attention from psychoanalytic practitioners in the 1950s, and psychoanalytic 
scholars wrote extensively about the condition during this time period. However, it was 
in 1980, when the third edition of the DSM was published, that it was formally 
introduced as a diagnosis in the United States.   
As noted by Sherry and Whilde (2008), BPD has been described as one of the 
more difficult and refractory conditions to treat, often because self-destructive behaviors 
frequently impede treatment (Linehan, 1993), because patients often drop out of 
treatment (Gunderson, Frank, & Ronningstam, 1989; Skodol, Buckley, & Charles, 1983; 
Stevenson & Meares, 1992), and because of high comorbidity with Axis I disorders, 
including major depression (Pilkonis & Frank, 1988; Reich & Noyes, 1987; Sullivan, 
Joyce, & Mulder, 1994; Zimmerman & Mattia, 1999), panic disorder (Reich and Noyes, 
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1987; Zimmerman & Mattia, 1999), bipolar disorder (Benazzi, 2000; Kay, Altshuler, 
Ventura, & Mintz, 1999), eating disorders (Gartner, Marcus, Halmi, & Loranger, 1989; 
Matsunaga et al., 2000), post traumatic stress disorder (PTSD) (Zimmerman & Mattia, 
1999) and substance abuse disorders (Driessen, Veltrup, Wetterling, John, & Dilling, 
1998; Nace, Davis, & Gaspari, 1991; Nace, Saxon, & Shore, 1983; Verheul, van den 
Brink, & Hartgers, 1998; Zimmerman & Mattia, 1999). Moreover, BPD is one of the 
most prevalent personality disorders found in inpatient and outpatient treatment settings 
(Widiger & Trull, 1993) and is relatively common in non-clinical populations as well 
(Gunderson & Zanarini, 1987). Research data suggests that the prevalence of BPD in the 
general population is about 1-2% and that it comprises about 10% of outpatients and 20% 
of inpatients (Torgersen, Kringlen, & Cramer, 2001).  
The assessment and diagnosis of BPD can be difficult, however, due to the 
aforementioned frequent comorbidity with other emotional disorders in the DSM-IV-TR. 
Diagnostic accuracy can only be as precise as the method used to perform the task. While 
the DSM-IV-TR’s medical approach may work well for diagnosing physical illnesses like 
the common cold, this dichotomous system fails to account for the many subtle nuances 
of human behavior or the intensity with which the behavior presents itself. For this 
reason, more precise and objective methods of understanding symptoms may be helpful 
in making these discriminations. Psychological testing can potentially be one method to 
provide more information to aid in patient diagnosis. One instrument that may be useful 
in this endeavor is the Rorschach Inkblot Test. 
BPD and the Rorschach Inkblot Method 
A search of the literature found 87 citations that examine the Rorschach Inkblot 
Test and BPD.  Of these, only four were peer reviewed journal articles whose scientific 
inquiry centered around variables from Exner’s Comprehensive System . In the first of 
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these articles, Exner compared individuals either diagnosed with schizophrenia, 
schizotypal personality disorder, and BPD (1986). He found that borderline subjects, as a 
group, either preferred an affectively driven, intuitive style of coping (Extratensive) or 
that they were undifferentiated in their coping style (Ambitent). The BPD group also 
contained more significant instances of protocols of individuals who were experiencing a 
stimulus overload that exceeded their coping capacities (D Score), leaving them 
vulnerable to psychological disorganization and disruption of functioning. Furthermore, 
even when situational factors were extracted, nearly half the BPD group was exposed to a 
chronic deficit in coping resources (Adjusted D), signifying immature psychological 
development, poor functional adjustment, and increased instances of behavioral acting 
out. These problems also appeared to be exacerbated because of additional findings 
indicating problems with affective modulation. However, relative to the other two groups, 
BPD patients showed little evidence of disordered thinking (Schizophrenia Index). With 
regard to reality testing, the BPD group appeared to view the world less conventionally 
and committed more distortions of reality (X-%) than the normative group but not to the 
same degree as the schizophrenic group. Lastly, unlike the other two research groups and 
unlike the normative group, the borderline protocols contained significantly more 
instances of a self-focus (Egocentricity Index) at the expense of the social environment. 
Another of four aforementioned journal articles studying BPD was a case study 
presenting two protocols of the same individual diagnosed with BPD, one administered at 
the start of psychotherapy and the other four years later (Murray, 1993). This article 
references a work performed in the early 1980s by Exner and Weiner (1982) on retest 
correlations over brief and long-term intervals, identifying inanimate movement and 
diffuse shading as signifying situational stressors and being unstable in terms of long-
term reliability, as environmental stressors tend to be relatively transient. In his case 
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analysis, Murray points out that the question of situational stress may be somewhat 
obscured for the borderline patient, as he/she often tends to be markedly affected by even 
minor stressors. So, what would be transient stressors for the non-BPD population might 
actually reflect long-term structural deficits in the tolerance of anxiety or defense 
operations. 
Skinstad, Troland, and Mortensen (1999) conducted an exploratory study to 
investigate the differences in Rorschach responses between two groups of inpatient 
alcoholics, one diagnosed with BPD and the other diagnosed with a mixed personality 
disorder (MPD). Results showed that, although not statistically significantly different 
from each other, both personality disorder groups produced signs of unconventional 
thinking (X-%). However, relatively few of any of the study participants demonstrated 
severe signs of reality testing problems. With regard to cognitive slippage, the BPD 
group showed a significantly higher proportion of Level 2 Special Scores, suggesting that 
their thinking was more susceptible to disorganization, compared to the MPD group. In 
addition, the BPD group also produced more human movement responses, indicating at 
least some increased interest in others, a higher degree of coping through ideational 
channels, and perhaps better overall coping, although the this trend did not reach 
statistical significance. The BPD group also demonstrated a stronger tendency to 
withdraw from social interaction and approach social interactions more aggressively than 
the MPD individuals, as demonstrated by their higher Isolation Index Scores and 
Aggressive Movement scores, respectively. This latter finding suggests that BPD 
individuals likely harbor more negative and hostile attitudes towards others and may even 
perceive other people and the environment as threatening.   
Lastly, a study by Hilsenroth, Eudell-Simmons, DeFife, and Charnas (2007) 
investigated the reliability, validity, and diagnostic efficiency of the Perceptual Thinking 
  
23 
Index (PTI), one of the many indices in the Comprehensive System. The PTI was shown 
to differentiate psychotic patients from nonpatients and from severe personality disorder 
patients, which included individuals diagnosed with BPD. Nonpatients had the lowest 
PTI scores. The severe Axis II group had intermediate scores, while the psychotic group 
had the highest PTI mean. The BPD group was also found to have significantly greater 
PTI scores than the nonpatient group. A cutoff of 3 points appeared to adequately 
differentiate between the psychotic patients and the nonpatient group as well as the less 
severe personality disorders from Cluster C. These results reflect the problems in 
thinking to which BPD patients are often susceptible. The significant difference over 
nonpatients likely reflects increased levels of paranoia, odd perceptual experiences, and 
transient psychotic episodes sometimes reported by these individuals. These findings 
reflect the ideas of Kernberg who described BPD individuals as living on a continuum 
between neurosis and psychosis in that their PTI scores lie in between nonpatients and 
patients diagnosed with a psychotic disorder (1984). 
In 2003, Mihura completed a similar review of the literature on BPD and the 
Rorschach (2006). She also notes that the majority of studies that included BPD groups 
used non-Comprehensive System scales. She includes in her review studies that address 
paranoia in BPD. While the data from other scoring systems support paranoia in the 
protocols of these individuals (Cooper et al., 1988; Stuart et al., 1990), no studies have 
explored these traits using the CS. Mihura also comments that the Trauma Content Scale 
may be useful a useful variable to study in BPD patients, as it may related to dissociation 
and/or the presence of past trauma, both of which are common in this patient group. 
Although not specifically related to BPD, Kamphuis, Kugeares, and Finn examined the 
Trauma Content Index’s ability to discriminate sexually abused individuals from those 
who were not abused. They found that this variable was able to accomplish this task. 
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However, this finding is relevant to BPD because of the well-documented relationship in 
the literature between childhood sexual abuse and a diagnosis of BPD in adulthood 
(Brown & Anderson, 1991; Goodwin, Cheeves, & Connell, 1989; Gunderson & Sabo, 
1993; Landecker, 1992; Laporte & Guttman, 1996; Paris, 1993). 
BIPOLAR DISORDER 
 
 Consulting the DSM-IV-TR (APA, 2000, p. 383) again to outline the 
necessary symptoms to diagnose bipolar disorder informs the reader that bipolar disorder 
exists in two different forms, Bipolar I (BP-1) Disorder and Bipolar II (BP-2) Disorder, 
with the former described as essentially being more severe than the latter. In either case, 
the individual in question must have experienced at least one manic or hypomanic 
episode. The manic episode consists of the following key elements: 
A. A distinct period of abnormally and persistently elevated, expansive, or 
irritable mood, lasting at least 1 week (or any duration if hospitalization is 
necessary).  
B. During the period of mood disturbance, three (or more) of the following 
symptoms have persisted (four if the mood is only irritable) and have been 
present to a significant degree:  
1) inflated self-esteem or grandiosity 
2) decreased need for sleep (e.g., feels rested after only 3 hours of sleep)  
3) more talkative than usual or pressure to keep talking  
4) flight of ideas or subjective experience that thoughts are racing 
5) distractibility (i.e., attention too easily drawn to unimportant or 
irrelevant external stimuli)  
6) increase in goal-directed activity (either socially, at work or school, or 
sexually) or psychomotor agitation 
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7) excessive involvement in pleasurable activities that have a high 
potential for painful consequences (e.g., engaging in unrestrained 
buying sprees, sexual indiscretions, or foolish business investments).  
C. The symptoms do not meet criteria for a Mixed Episode. 
D. The mood disturbance is sufficiently severe to cause marked impairment 
in occupational functioning or in usual social activities or relationships 
with others, or to necessitate hospitalization to prevent harm to self or 
others, or there are psychotic features.  
E. The symptoms are not due to the direct physiological effects of a 
substance (e.g., a drug of abuse, a medication, or other treatment) or a 
general medical condition (e.g., hyperthyroidism).  
F. Note: Manic-like episodes that are clearly caused by somatic 
antidepressant treatment (e.g., medication, electroconvulsive therapy, light 
therapy) should not count toward a diagnosis of Bipolar I Disorder. 
The hypomanic episode differs in several key ways. First, the upward change in 
mood needs only to last for a period of four days, rather than seven, and lacks the 
descriptor “abnormal,” presumably because the symptoms of the hypomanic episode are 
less intense and may not necessarily appear as problematic to the onlooker in the way that 
they might when witnessing full mania. Even though the hypomanic behavior might not 
necessarily be abnormal compared to other individuals, the DSM-IV-TR does require that 
it be an “unequivocal change in functioning that is uncharacteristic of the person when 
not symptomatic” (APA, 2000, p.393). This change in mood must also be “observable by 
others” (APA, 2000, p. 393). Whereas an onlooker might not easily recognize that a 
problem exists, someone familiar to the person would be able to identify a difference 
relatively easily. Lastly, the criteria for hypomania specify that there is not a marked 
impairment in functioning, that hospitalization is not required as a result of the onset of 
the mood change, and that there is no psychosis present (APA, 2000, p. 393). 
In addition the to symptoms of mania and/or hypomania, individuals can receive a 
diagnosis of BP-1 Disorder or BP-2 Disorder if it can be determined that there is 
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evidence in the history to suggest that a manic or hypomanic episode has previously 
occurred and if the patient is currently experiencing or has also ever experienced a major 
depressive episode, as outlined by the following DSM-IV- TR (APA, 2000, p. 393) 
criteria: 
A. Five (or more) of the following symptoms have been present during the 
same 2-week period and represent a change from previous functioning; at 
least one of the symptoms is either 1) depressed mood or 2) loss of interest 
or pleasure. 
B. Note: Do not include symptoms that are clearly due to a general medical 
condition, or mood-incongruent delusions or hallucinations.  
1) depressed mood most of the day, nearly every day, as indicated by 
either subjective report (e.g., feels sad or empty) or observation made 
by others (e.g., appears tearful). Note: In children and adolescents, can 
be irritable mood.  
2) markedly diminished interest or pleasure in all, or almost all, activities 
most of the day, nearly every day (as indicated by either subjective 
account or observation made by others)  
3) significant weight loss when not dieting or weight gain (e.g., a change 
of more than 5% of body weight in a month), or decrease or increase 
in appetite nearly every day. Note: In children, consider failure to 
make expected weight gains.  
4) insomnia or hypersomnia nearly every day  
5) psychomotor agitation or retardation nearly every day (observable by 
others, not merely subjective feelings of restlessness or being slowed 
down)  
6) fatigue or loss of energy nearly every day  
7) feelings of worthlessness or excessive or inappropriate guilt (which 
may be delusional) nearly every day (not merely self-reproach or guilt 
about being sick)  
8) diminished ability to think or concentrate, or indecisiveness, nearly 
every day (either by subjective account or as observed by others)  
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9) recurrent thoughts of death (not just fear of dying), recurrent suicidal 
ideation without a specific plan, or a suicide attempt or a specific plan 
for committing suicide  
C. The symptoms do not meet criteria for a Mixed Episode.  
D. The symptoms cause clinically significant distress or impairment in social, 
occupational, or other important areas of functioning.  
E. The symptoms are not due to the direct physiological effects of a 
substance (e.g., a drug of abuse, a medication) or a general medical 
condition (e.g., hypothyroidism).  
F. The symptoms are not better accounted for by Bereavement, i.e., after the 
loss of a loved one, the symptoms persist for longer than 2 months or are 
characterized by marked functional impairment, morbid preoccupation 
with worthlessness, suicidal ideation, psychotic symptoms, or 
psychomotor retardation. 
BP-1 Disorder has been found to be equally prevalent in men and women in all 
epidemiologic studies conducted in both the United States and Europe since 1990. 
However, men are more likely to only experience unipolar mania, have either a 
depressive or manic episode at an earlier age, and have lengthier manic episodes, while 
women have been shown to experience mixed and major depressive episodes and to 
receive treatment for any of the three types of bipolar related episodes more often than 
men (Grant et al., 2005). BP-1 appears to be equally prevalent among African-Americans 
and Caucasians but affects Latino and Asian populations less frequently, relative to the 
other two groups.   
The symptomatic course of BP-1 is highly recurrent, frequently chronic, and 
correlated with functional impairment and early mortality (McIntyre & Konarski, 2004). 
It is also associated with frequent hospitalizations, increased suicide risk, high treatment 
costs, and impaired occupational functioning (Francis, Kahn, Carpenter, Docherty, & 
Donovan, 1998; Peele, Xu, & Kupfer, 2003; Harrow, Goldberg, Grossman, & Meltzer, 
1990). Research findings suggest substance abuse, anxiety disorders, Axis II disorders, 
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and eating disorders are commonly comorbid in BP-1, further complicating diagnosis, 
treatment, and outcomes (McIntyre et al., 2006; Grant et al., 2005). Symptom severity, 
functional and occupational disability, earlier age of onset of bipolar related episodes, 
higher rates of suicidality, medication resistance, relapse, and poorer outcome have all 
been linked with BP-1 when it appears with these comorbid problems (George, 
Miklowitz, Richards, Simoneau, & Taylor, 2003; Goldberg, Garno, Leon, Kocsis, & 
Portera, 1999; Sonne, Brady, & Morton, 1994). A 1991 economic investigation 
conducted by Wyatt and Henter (1995) that focused on the monetary cost of bipolar 
disorder estimated that the economic cost of the disease to the U.S. economy based on a 
lifetime prevalence rate of 1.3% to be $45 billion per year. A 2001 figure proposed by 
Begley et al. calculated the lifetime cost of incident cases from 1998 to be $24 billion 
based on a 1.6% lifetime prevalence rate. 
While other presentations do commonly occur, the initial onset of BP-1 symptoms 
is most often characterized by the presence of sleep disturbance, low mood, and anxiety 
(McElroy et al., 2001). Poor insight is also common in BP-1, occurs most often during 
manic episodes, and is predictive of treatment non-compliance and poor outcome 
(Ghaemi & Rosenquist, 2004). Comorbid anxiety in BP-1 dramatically increases the risk 
of having poor insight in addition to increased suicidality, additional episodes of the 
illness, and hospitalizations (McIntyre et al., 2006). One study found that nearly half, 
48.5%, of its BP-1 sample met diagnostic criteria of at least one comorbid anxiety 
disorder during the twelve months of the study (Grant et al., 2005).  Estimates of suicide 
attempts at least once during the lifetime of individuals diagnosed with BP-1 range 
between 25% and 50%, among the highest of all psychiatric disorders (Goodwin & 
Jamison, 1990), and between 9% and 19% of all bipolar patients die due to completed 
suicide. Risk factors for increased suicide attempts include early onset, numerous 
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depressive episodes, history of mania induced by antidepressants, and a family history of 
a suicide attempt (Slama et al., 2004). 
Bipolar Disorder and the Rorschach Inkblot Method 
A literature search for peer reviewed, North American, journal articles after 1980 
using the Comprehensive System identified only one studies meeting these requirements. 
The first, an investigation by Singer & Brabender (1993) compared Rorschach protocols 
of three different mood disorder groups: unipolar depressed, bipolar depressed, and 
bipolar manic. The results found 70% of manic protocols contained at least one Level II 
Special Score, whereas only 33% of bipolar depressed and 23% of unipolar protocols did. 
Manic subjects also demonstrated considerably more impairment in reality testing (X-%) 
compared to the other two groups. And,  their protocols indicated that reality testing was 
markedly hindered by feelings of hostility (S-%). The manic group was more likely than 
the bipolar depressed group to rely on intellectualization as a defense, and one-third of 
the manic subjects obtained an elevated SCZI score, increasing the chance that this group 
was experiencing a higher degree of psychotic thinking. The bipolar depressed group in 
this study also showed a high degree of cognitive slippage, but their problems in this area 
were manifest through increased Level I Special Scores whereas their manic counterparts 
earned significantly higher Level I and Level II Special Scores. Level I Deviant 
Responses were also significantly higher in all bipolar patients, while bipolar manic 
patients had significantly higher Level II Deviant Responses. The bipolar depressed The 
bipolar depressed subjects also were different than the two other groups in their 
organizational activity (Zf) and cognitive sophistication (DQ+), both of which were lower 
in the bipolar depressed subjects. In addition, the DEPI was found to more successfully 




 One additional study will be discussed here that did not meet the search 
criteria but is worth noting; it was conducted in Isreal (Mandel, Last, Belmaker, & 
Rosenbaum, 1984). It compared the Rorschach protocols of 35 bipolar patients in a 
euthymic state with Exner’s normative group (Exner, 1978). Most study participants were 
taking lithium. Several variables were identified that were found to be significant, varied 
one or more standard deviations from the mean, and were true for 50% or more of the 
cases. Despite their euthymic state, their affect was much less well modulated than the 
control group (FC:CF+C). Eighty-three percent of the bipolar group had an FC score that 
was two deviations from the normative mean. Reality testing (F+%) was also low, as was 
organizational activity (Zf). Complexity of cognitive activity was also lower than 
expected (Blends). Bipolar subjects also appeared less interested in others (H+Hd), as 
well as less likely to rely on thinking channels of problem solving (M). Despite being 
stabilized on medication, special scores still reflected problems with flawed thinking. 
Lastly, pair responses were lower than the reference group, suggesting that these 
individuals were avoiding self-focusing. 
DISTINGUISHING BPD FROM BIPOLAR DISORDER 
Controversy exists in research literature about whether bipolar disorder and BPD 
are the same problem or whether they are two diagnostically different classifications. 
This question arises because of overlap of symptoms that they both share (Magill, 2004; 
Howland & Thase, 1993). In patients who manifest both impulsivity and affective 
instability, making the determination between the two problems can be difficult, as it 
requires differentiating between whether or not these symptoms occur during discrete 
episodes or whether or not they are part of an endogenous pattern of functioning. Patients 
who also present with unstable relationships and persistent destructive behaviors can add 
even more complexity to this diagnostic conundrum.  
  
31 
Before attempting to differentiate these two disorders from each other, an 
understanding of the extent to which these problem co-occur is useful. Several studies 
have investigated this relationship. Deltito et al. reported that nearly one-third of their 
BPD cohort had a history of a spontaneous manic or hypomanic episode (2001). Akiskal 
et al. (1985) found that in their 100 subject sample of individuals diagnosed with BPD, 
mood disorders were the most common comorbid Axis I problem. Seven of their subjects 
met criteria for cyclothymia and 17 met criteria for Bipolar Disorder II. At the 36-month 
follow-up, significantly more of the BPD group experienced a manic or hypomanic 
episode than did the control group. Zanarini et al. (1998) reported that more patients 
diagnosed with BPD also received a Bipolar II diagnosis, compared with all other Axis II 
disorders. Data from Levitt, Joffe, Ennis and MacDonald (1990) showed that cyclothymia 
occurred more often in BPD patients than in patients carrying other personality disorder 
diagnoses.   
Multiple additional studies have shown that BPD is one of the most frequently 
occurring Axis II disorder in patients diagnosed with BP-I. Brieger, Ehrt, and Marneros 
(2003) explored the relationship of personality disorders with affective disorders. In their 
sample, 51% of participants diagnosed with a unipolar depression and 38% of those 
meeting criteria for a bipolar disorder also met criteria for a comorbid Axis II disorder. 
The most frequent personality disorders found were obsessive-compulsive, borderline, 
and narcissistic and avoidant. Cluster C disorders, especially avoidant personality 
disorder, occurred significantly more frequently in patients with unipolar depression than 
in bipolar patients. Narcissistic personality disorder occurred significantly more often in 
bipolar than in unipolar patients. Twelve percent of the unipolar sample was found to 
have an accompanying BPD diagnosis, while just 7% of the bipolar group received an 
additional diagnosis of BPD. Üçok, Karaveli, Kundakçi, and Yazici (1998) found similar 
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results, finding nearly half of their outpatient bipolar sample meeting criteria for a 
personality disorder. Of the total bipolar sample, 10% received an additional diagnosis of 
BPD. In a private practice, outpatient sample, Benazzi (2000) found the incidence of 
BPD to be lower in individuals receiving medication treatment for bipolar disorder. In his 
sample, only 1.5% of bipolar patients received an additional BPD diagnosis. However, 
the incidence of BPD rose sharply, to 12%, when patients diagnosed with BP-2 Disorder 
were also examined, suggesting the possibility of greater overlap with BP-2 Disorder 
than BP-1. While some studies report slightly different findings, the majority of the data 
examining the connection between the bipolar spectrum and BPD indicate that BPD and 
BD-1 occur together more frequently than BPD does with most other psychiatric 
diagnoses. Likewise, there is a strong link between the bipolar spectrum and the 
possibility of a comorbid BPD. It is difficult to determine if these results reflect true 
comorbidity or variations of a single disorder along a spectrum. 
Researcher conceptualizations about the bipolar spectrum continue to broaden.  
Akiskal asserts that the bipolarity not only includes depression, mania, and hypomania 
but encompasses more subtle forms of hypomanic activation such as cyclothymia, 
lifelong intermittent mini-depressions alternating with short hypomanic periods with 
infrequent euthymia, and with hyperthymic temperament, a “permanently elevated 
baseline of hypomanic adjustment” (1996, p. 7S). Akiskal believes that these less 
pronounced forms of mania and/or depression are softer forms of bipolar disorder and fall 
with the broader scope of the bipolar spectrum. He cites a relatively common patient 
prototype of an individual who presents for care with cyclothymic features, having had 
soft, alternating cycles of hypomania and depression beginning in late adolescence that 
are characterized by abrupt shifts from one mood state to the next, with both elevated and 
depressed states only lasting a few days with short, infrequent periods of affective 
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stability. Akiskal argues that this above described vignette characterized by rapidly 
shifting affect is also seen in individuals diagnosed with BPD and that these rapid shifts 
in affect can become conceptualized by clinicians as character flaws or personality 
deficiencies rather than mood disorders.   
Hirschfeld (2001) calls for broadening the concept of bipolar disorder, also 
advocating for a spectrum approach. He includes in mixed states, hyperthymic 
temperament, major depressive episodes, and describes a mixed state as one that includes 
dysphoria, racing thoughts, irritability, at least moderate anxiety, high fatigue, panic 
attacks, suicidal ideation and parasuicidal behavior, all of which could easily be 
interpreted as indicators of BPD. In a similar vein, Deltito et al. (2001) examined signs 
and symptoms of bipolarity in BDP patients using five indicators:  history of mania, 
history of hypomania, bipolar temperaments, response to medication treatment typical of 
bipolar disorder, and family history of bipolar disorder.  Results found that depending 
how rigorous (mania) or mild (family history) the criteria were that were applied, 
between 13 and 81% of the BPD participants demonstrated signs relevant to the bipolar 
spectrum.  When the researchers restricted the criteria to only Bipolar I or II Disorder, 
44% of the BPD sample fell on the bipolar spectrum.   
Ghaemi, Ko and Goodwin (2002) have called for an additional diagnostic 
category, bipolar spectrum disorder, to encompass all other potential forms of bipolarity 
that are not accounted for by BD-I or by Bipolar II Disorder.  They suggest that the 
criteria should require at least one current or past major depressive episode but no 
spontaneous manic or hypomanic episodes.  In addition, one of several combinations of 
the following criteria would also be required: a positive family history of BD-1 or BP-2 
Disorder, mania or hypomania induced by antidepressant pharmacotherapy, hyperthymic 
temperament, brief and/or recurrent major depressive episodes, early age of onset of first 
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major depressive episode, post-partum depression, poor response to multiple trials of 
antidepressant medication, and re-emergence of symptoms while taking a once 
therapeutic dose of an antidepressant.   
Beyond the overlap of symptoms between BPD and the bipolar disorders, several 
reasons have been suggested to explain what these researchers describe as a misdiagnosis 
of bipolar spectrum patients as BPD (Magill, 2004). First, prior to meeting criteria for 
one of the more current rigorous definitions of bipolar disorder in the DSM-IV-TR, these 
patients experience years of fluctuations in mood and affect that highly resemble bipolar 
disorder. Furthermore, in addition to the manic/hypomanic and depressive episodes, the 
sub-threshold episodes of either mood state can all be fertile ground for the genesis and 
maintenance of interpersonal conflicts and maladaptive character development. Also, 
individuals who experience cyclothymia, those whose mood symptoms are often difficult 
to distinguish as clearly manic or clearly depressive, because of the rapid shifting, can be 
misclassified as BPD. And, when not fully symptomatic, these patients experience fewer 
asymptomatic periods of time, thereby appearing to exhibit more characteralogical 
problems than mood related ones. Howland and Thase add that the etiology of issues 
surrounding marital discord, promiscuity, poor work performance, and substance abuse 
are often ascribed to a personality disorder, rather then complications of a mood 
disturbance (1993). 
As a result of the debate about the legitimacy of BPD, multiple investigations 
have examined its validity in closer detail. In an early study, Gaviria, Flaherty, and Val 
(1982) compared the psychiatric records of two groups of patients, one diagnosed with 
BP-1 only and the other with BP-1 and BPD. Individuals with more than one diagnosis 
had higher rates of psychiatric problems in childhood and adolescence, lower school 
performance, and more loss and/or separation from primary attachment figures during 
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childhood. Furthermore, patients with comorbidity reported their first mood disorder at 
an earlier age and reported significantly more psychotic symptoms during than did the 
BP-1 only group. The records of patients with more than one diagnosis also reflected 
poorer compliance with treatment and were terminated from treatment significantly more 
often than their counterparts, who were more likely to end treatment on more positive 
terms.     
Sanislow et al. (2002) tested two validity models using the DSM-IV criteria for 
BPD. Their first group was comprised psychiatric inpatients and outpatients who met 
Axis II criteria for borderline, obsessive-compulsive, schizotypal, and avoidant 
personality disorders using The Diagnostic Interview for DSM-IV Personality Disorders 
(Zanarini, Frankenburg, Sickel , Yong, 1996). The comparison group contained 
individuals who met criteria for major depressive disorder but not for an Axis II 
diagnosis. Confirmatory analysis showed good statistical fit with both a one factor model 
and a three factor model, although the latter demonstrated a significantly better fit to the 
data, providing empirical support the existence of BPD. The first factor of the three, 
described as "disturbed relatedness," included the DSM criteria unstable relationships 
(criterion number 2), identity disturbance (number 3), and chronic feelings of emptiness 
(number 7). This factor, reflecting a impaired sense of self and relatedness to others, 
might be viewed as an essential feature of BPD because they exhibit much of the 
symptomatic interpersonal behavior typically observed in these patients. The second 
factor, "behavioral dysregulation," included criteria for impulsivity (number 4) and 
suicidality and/or self-mutilation behavior (number 5). It captured the most emergent of 
the symptomatic behavior relevant to treatment and differed from the other factors in that 
the criteria that it comprised were observable behaviors as opposed to character traits or 
tempermentally related constructs. The third factor, "affective dysregulation," consisted 
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of criteria for affective instability (number 6), inappropriate anger (number 8), and 
avoidance of abandonment (number 1). It is likely related to stress tolerance, difficulty 
coping, and inability to contain behavior and words during difficult times.   
Zanarini et al. (1998) assessed the lifetime rates of occurrence comorbid Axis I 
disorders in patients with BPD versus a comparison group, each of whom met criteria for 
a different personality disorder. The data suggested that anxiety disorders were almost as 
common among borderline patients as mood disorders but co-occurred in BPD patients at 
a much higher rather than the comparison group. Posttraumatic stress disorder was a 
common although not universal comorbid disorder among BPD patients, a finding 
inconsistent with the belief that BPD is actually a form of chronic PTSD. And, male and 
female borderline patients differed in their impulsivity. Substance abuse disorders were 
more common among male borderline patients, whereas eating disorders were more 
common among female patients. And, a lifetime pattern of complex comorbidity had 
strong positive predictive power for the BPD diagnosis as well as a high level of both 
sensitivity and specificity. Zanarini et al. (1998) concluded that multiple Axis I diagnoses 
over the lifetime of an individual also provide support for the BPD diagnosis.   
Gunderson and Elliott (1985) suggest several hypotheses to explain the 
relationship between BPD and the bipolar spectrum. One theory is that the mood disorder 
could be the primary problem and that the personality disorder results because 
developmental milestones related to emotional growth as not met as a consequence of the 
mood problems. Or, conversely, the coping deficits inherent in the personality disorder 
could contribute to the genesis of bipolar symptoms to which the individual lacks 
resilience. Third, both BPD and the bipolar spectrum are unrelated and that they both 
have high rates of occurrence in the population relative to other disorders. Lastly, the 
signs and symptoms of bipolar disorder and BPD come from multiple sources and, at 
  
37 
times, result in the development of an Axis I and an Axis II problem. Given their finding 
that individuals diagnosed with BPD and bipolar disorder commonly experience an 
earlier age of onset of a mood disorder, Gaviria et al. propose that individuals with BPD 
who also possess a greater genetic vulnerability to a mood disorder may be more 
susceptible to developing mood related symptoms at an earlier age (1982). Another 
possibility is that those who begin with a genetic vulnerability are at a greater risk of 
developing psychopathology earlier and may be more vulnerable to developing either 
BPD or bipolar disorder, with the individual signs and symptoms differing depending on 
the stressors, the social support available, and temperament (Gunderson & Elliott, 1985). 
Finally, Magill believes that sufficient evidence exists to substantiate BPD as a unique 
entity, separate from bipolar disorder. She recommends careful questioning about the 
patient’s personal and family history in order to understand better the course of the 
individual’s illness and potentially long-standing patterns of behaving and relating 
(2004). 
SUMMARY & PROPOSED STUDY 
The Rorschach Inkblot Test is a perceptual-cognitive task in which the examinee 
must organize a response to an ambiguous stimulus. The manner in which an individual 
approaches this task is thought to be similar to how one responds to ambiguity in daily 
life. The end result of this activity provides valuable information about how individuals 
people focus their attention, perceive people and events, reflect on their experience, 
manage emotions and stress, and view themselves and others. Despite criticism of the 
CS’s psychometric properties, the Rorschach has been consistently shown to demonstrate 
ICCs of greater than .90 for the majority of its variables. In adults, the short- and long-
term stability of most CS variables exceeds .75, and 19 of its core variables have 
demonstrated one-year or three-year retest correlations of .85 or higher. In children its 
  
38 
variables have been shown to move along a developmental trajectory that maps onto 
cognitive and emotional theories of development. And, meta-analysis of MMPI and 
Rorschach protocols suggests that these instruments possess similar mean validity 
coefficients, both of which are among the highest ranking of all psychological assessment 
tools. In addition, the Rorschach CS includes normative reference data on 600 nonpatient 
adults, 1390 children ages 5 to 16, and several patient groups.  And, in response to 
criticism, a new reference sample was recently gathered that revealed that the norms have 
changed little in the past two decades. 
In terms of its utility, the Rorschach can be helpful in assessing patients who 
conceal psychopathology or who are attempting to positively malinger, has been 
demonstrated to be effective at identifying psychosis, and provides a valuable description 
of an individual’s personality traits that can illuminate problems and inform treatment 
planning. Despite these assets, some Rorschach research has been criticized sharply for 
its methodology. And, the instrument itself has been criticized because some of its 
variables have not been demonstrated empirically to measure they purport to measure and 
for not discriminating well among certain diagnoses.  
BPD and bipolar disorder are both illnesses that case significant functional 
impairment, are costly in terms of treatment and lost productivity, and are associated with 
high comorbidity rates and with each other. There is debate in the literature as to whether 
they are each distinct diagnostic categories or if they are actually different labels for the 
same problem.  Relatively few studies have been conducted of the CS in the past 25 years 
that that examine the Rorschach’s ability to identify these two disorders separately. 
Moreover, no studies exist that have attempted to ascertain whether the CS can 
discriminate between them. While it is unlikely that the Rorschach will be able to 
definitively place an individual into a distinct diagnostic category, any additional 
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assistance that an assessment instrument could scientifically provide would be potentially 
helpful. Furthermore, if the Rorschach were able to be able to discriminate between these 
two groups, it would also provide additional support for the idea that BPD and bipolar 
disorder are distinct diagnostic entities.   
The current study has one central purpose, to determine whether or not the CS for 
the Rorschach Inkblot Test can effectively discriminate between individuals diagnosed 
with BPD and those diagnosed with bipolar disorder.  Previously conducted, peer-
reviewed studies since 1985 have uncovered CS variables that were statistically 
significant in BPD and in bipolar groups when examined separately. However, there have 
been relatively few such investigations, making the body of research with CS variables 
small in this area. It would be valuable to know whether or not the CS is a useful tool in 
making diagnostic determinations for these two disorders, especially given the previously 
discussed criticisms of the instrument. A second goal of the current study is to uncover 
variables that add to the existing body of knowledge about the CS and bipolar disorder 
and BPD independently. Some of these may be variables that have not been previously 
studied as relevant to either BPD or bipolar disorder.  Others may replicate findings that 
already exist.  Moreover, if the Rorschach could help classify these individuals and 
uncover distinct differences between them in their test results, these data would also lend 
support for the idea that these are indeed two different disorders, a tertiary goal of the 








Chapter 3: Methodology 
PARTICIPANTS 
The participants for this study will be drawn from a preexisting database of 
psychological testing files at Austin State Hospital (ASH), an inpatient tertiary care 
psychiatric hospital in Austin, Texas. The cases to be reviewed were completed over an 
11-year period, spanning from 1998-2009.   
Prior to data collection, a power analysis using GPower (Erdfelder, Faul, & 
Buchner, 1996) was conducted to determine the appropriate number of subjects for this 
study. Univariate analyses will be used given there is no theoretical overlap between the 
Rorschach variables being studied. Using this data analysis approach, it was determined 
that sufficient power would be obtained with 159 participants with a medium effect size 
(power =.8).   
The following eligibility criteria will be utilized for the study. Patients must have 
been administered the Rorschach by a advanced practicum student or intern enrolled in a 
doctoral-level clinical or counseling psychology training program under the supervision 
of a licensed psychologist, or by a staff psychologist at ASH. All included Rorschach 
protocols will have been administered in accordance with the Comprehensive System 
guidelines (Exner, 1993). Only protocols that contain at least 14 responses and those that 
are considered valid under the Comprehensive System guidelines will be included. 
Exner’s research suggests Rorschach variables are less valid and reliable when protocols 
contain fewer than 14 responses (1991).   
Medical records will be reviewed for working psychiatric diagnoses based on the 
DSM-IV-TR (APA; 2000). Patients will be included if they have a DSM-IV diagnosis of 
Borderline Personality Disorder or BP-1 Disorder. BP-1 diagnosis will be further divided 
into Bipolar Manic and Bipolar Depressed groups. Grouping variables for the study will 
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be Bipolar Manic, Bipolar Depressed and Borderline Personality Disorder. Protocols of 
patients will be excluded if they meet criteria for both diagnoses simultaneously. In the 
two bipolar groups, the with and without psychotic features subtypes will be collapsed for 
the analysis. Patients who meet the follow criteria will be excluded from the study: 
documentation of mental retardation (including suspicion in the medical record), those 
admitted for forensic psychiatric evaluations, substance abuse related psychosis, and/or 
those suspected of having an disorder of an organic etiology.  
Table 1 
Summary of Inclusion and Exclusion Criteria 
 Inclusion Criteria Exclusion Criteria 
Rorschach  Completed Rorschach by 
trained professional 
 
Use of Exner 
Comprehensive System 
Fewer than 14 responses 
 
 
Diagnostic Borderline Personality 
Disorder 
 
Bipolar I, Current Episode 
Manic  
 
Bipolar I, Current Episode 
Depressed  
 








Substance Abuse Psychosis 
 
PROCEDURES 
Participants will be drawn from the assessment archives at ASH. A psychological 
assessment at this facility typically consists of a Rorschach, one objective assessment 
measure, a clinical interview, and a review of the patient’s records. Assessment batteries 
may also include other measures appropriate to the individual case and/or to the referral 
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question(s) generated by the treatment team. In cases of suspected malingering, a SIRS 
(Structured Interview of Reported Symptoms; Rogers, Bagby, & Dickens, 1992) may 
also be administered. Although all patients in the proposed study completed Rorschach 
Inkblot tests, they may have also been administered other measures not used in the 
current study. The order in which the testing instruments are administered varies, usually 
as a function of pragmatics regarding time available, scheduling, and the patient’s ability 
to tolerate undergoing testing on a particular day. It is unlikely that the order of 
administration of the instruments in the test battery would have affected the validity of 
the Rorschach results.   
Because patient records over an 11-year period are being used, the assessments 
will have been administered by multiple examiners. However, as previously noted, all 
examiners are be advanced practicum students enrolled in a doctoral-level clinical or 
counseling psychology training program, pre-doctoral psychology interns, or psychology 
staff at the hospital. All Rorschach examiners will have received formal classroom 
training and supervision in projective personality assessment. In addition, on-site training 
for students and interns at ASH typically includes performing a mock Rorschach with a 
supervisor, observing assessment sessions, being observed by a supervisor, and 
supervision of test administration and scoring, depending on prior level of experience.   
Prior to data collection, permission for the proposed study will be obtained from 
the University of Texas at Austin’s Institutional Review Board (IRB) and from the IRB at 
ASH. Furthermore, the proposed study will adhere to the ethical standards of the 
American Psychology Association and to the “Policies and Procedures Governing 
Research with Human Subjects” of the University of Texas at Austin and of the Texas 
Department of Mental Health and Mental Retardation.   
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To protect the anonymity of each subject, no identifying information will be 
recorded from patient medical records. Following the initial selection of patients for the 
study, patients will be assigned a numeric code to protect their identities. Data obtained 
will be stored in a locked file cabinet accessed only by the researchers involved in the 
proposed study. Inter-rater reliability will be assessed by randomly selecting 
approximately 25% of the Rorschach protocols and comparing the principal 
investigator’s scoring to the original Rorschach scoring. These protocols will be scored 
without knowledge of the diagnosis so the researcher will be blind to group membership 
during the scoring process. The Kappa coefficient will be calculated to determine inter-
rater reliability. Estimates of inter-rater reliability are considered excellent if greater than 
.74, good if they range from .60 to .74, and fair if they range from .40 to .59 (Fleiss, 
1981). Finally, selected information from patient charts will be reviewed. Demographic 
information, such as, sex, age, marital status, and race will be collected. Additional 
treatment related information will be collected such as length of stay, number of days in 
hospital prior to testing, number of Axis I and Axis II diagnoses, and GAF scores at 
admission will be collected.   
The principal investigator of the current study has had extensive training and 
supervision in the use of the Exner CS (1993). He has had a total of seven years of 
supervised experience in Rorschach administration and scoring. Three of these years 
included supervised experience in administration, scoring, and interpretation that 
included weekly hour-long supervision sessions with one of the committee members of 
the current study and has attended four intensive weekend-long seminars with another 




Rorschach Inkblot Method     
The Rorschach Inkblot method is a performance-based instrument that measures 
several aspects of an individual’s personality (Weiner, 2004). It is comprised of ten 
inkblots that are presented to the examinee with the instructions, “What might this be?” 
Responses are recorded verbatim and coded based on a variety of dimensions, including, 
among others, the exact portion of the blot used, the quality of the percept as it relates to 
the appropriateness or lack thereof of the form contours of the blot, color, shading, and 
content. From these codes ratios are calculated that provide information about an 
individual’s reality testing, perception of self, and others, emotional functioning, and 
thought processes (Exner, 1993). Currently, the most reliable and valid system for 
administering and scoring the Rorschach is Exner’s Comprehensive System (CS) 
(Viglione & Hilsenroth, 2001).  
Multiple studies have focused on the inter-rater reliability of the CS variables 
(Acklin, McDowell, Verschell, & Chan, 2000; Meyer, 1997 a, b; Meyer et al., 2002; 
Viglione & Hilsenroth, 2001; Viglione & Taylor, 2003). A review article by Viglione & 
Hilsenroth (2001) found that studies conducted in the past 20 years demonstrate that 95% 
of CS variables can be coded with good (ICC > .60) to excellent (ICC > .74) inter-rater 
reliability.   
Tables 3.2 presents a summary of the Rorschach variables that were included in 
this study. These specific variables were selected for inclusion based on a review of the 
literature and their theoretical importance to understanding and discriminating among 






Rorschach Variables Believed to Discriminate among Borderline Personality Disorder, 
Bipolar I Manic, and Bipolar II Depressed Groups 
 
Variable Abbreviation Definition 
Erlebnistypus EB A ratio of internal coping resources available for 
problem solving related to thinking on the left side and 
feeling on the right side. 
Adjusted D Adj D An indicator of the ability to maintain emotional, 
verbal, and behavioral control. A score of less than 
zero suggests a chronic state of being overwhelmed, 
poor stress tolerance, difficulty adapting to stress, and 
ineffective problem solving. 
Food Fd Any response containing food. Indicates the presence 
of an immature dependence on others to meet one’s 
needs. Suggests a likelihood of taking from others 
while giving little in return. 
Hypervigilance 
Index 
HVI This index is comprised of nine items. When a certain 
combination of items is reached, the index is 
considered positive. It signifies a trait in which the 
person uses energy to maintain a constant state of 
preparedness based on a mistrusting attitude toward the 
environment during development related to a sense of 




AG A response containing verbal or behavioral aggression.  
Signifies a tendency to not anticipate cooperation with 




TC/R A ratio of the sum of all blood, sex, morbid, and 
aggressive movement responses. Has been interpreted 
as a tendency toward psychotic regression and as a 




3r+2 / R Measures the degree to which a person thinks about 
him-/herself vs. others. Elevations indicate excessive 
concern with one’s own thoughts, feelings, and 





Table 2 (continued) 
 
White Space 
with (-) Form 
Quality 
S- Percepts incorporating white space are interpreted as 
negativism, anger, or oppositionality. With combined 
with poor form quality, it denotes the loss of reality 




PTI A 5-criteria index that draws from indices of 
perceptual distortion and cognitive slippage. The 
likelihood of psychosis increases with each additional 
positive indicator over three.  
Developmental 
Quality 
DQ+ Instances when the response reflects well-organized, 




DR1 Responses that detach from the task and reflect mild 




DR2 Similar to DR1 but are considered to reflect more 
serious difficulties in the ability to maintain focus on 
the task at hand and reflect disjointed and impulsive 
cognition. 
RESEARCH QUESTIONS 
The primary aim of the current study is to determine whether the Rorschach, 
using the CS, is capable of discriminating among Borderline Personality Disorder, BP-1 
Disorder with current manic symptoms, and BP-1 Disorder with current depressed 
symptoms.  Although these disorders share many commonalities, a review of the 
literature indicated that several variables may have the potential to provide such 
discrimination. The hypotheses for each of these variables as well as the proposed 
analyses and expected results are listed below:  
 
Research Question 1:  Can a patient’s coping style, as measured by the Rorschach CS 
variable Erlebnistypus (EB), discriminate among Borderline Personality, Manic Bipolar, 
and Depressed Bipolar groups?  
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Hypothesis:  Ambitent coping style will be significantly more associated with 
Borderline Personality than with either Bipolar group.  
Proposed Analysis:  A generalized linear model analysis will be conducted with 
diagnosis (Borderline Personality, Bipolar Manic, and Bipolar Depressed) as grouping 
variable 1 and coping style (Ambitent, Introversive, Extratensive) as grouping variable 2. 
If a significant main effect for the independent main variable, a follow-up contrast 
between groups will also be conducted.  
 
Research Question 2:  Can a patient’s index of his/her overall ability to maintain control 
during stressful periods (as measured by the Adjusted D-score in the Rorschach CS) 
distinguish among Borderline Personality, Manic Bipolar, and Depressed Bipolar 
groups?  
Hypothesis:  The Borderline Personality group will demonstrate significantly 
lower Adjusted D-scores than either the Manic Bipolar or the Depressed  Bipolar group. 
Proposed Analysis:  A one-way ANVOA will be conducted with Group as the 
independent variable and the Adjusted D-score as the dependent variable. If the effect is 
found to be significant, a Tukey’s posthoc analysis will be conducted.  
 
Research Question 3:  Can the number of food responses in a patient’s protocol 
distinguish among Borderline Personality, Manic Bipolar, and Depressed Bipolar 
groups?  
Hypothesis:  The protocols in the Borderline Personality group will contain 




Proposed Analysis:  A one-way ANVOA will be conducted with Group as the 
independent variable and food responses as the dependent variable. If the effect is found 
to be significant, a Tukey’s posthoc analysis will be conducted. 
 
Research Question 4:  Can the number of positive factors on the Hypervigilance Index 
(HVI) distinguish among Borderline Personality, Manic Bipolar, and Depressed Bipolar 
groups?  
Hypothesis:  The HVI scores in the Borderline Personality group will be 
significantly higher than in either the Manic Bipolar or the Depressed Bipolar group. 
Proposed Analysis:  A one-way ANVOA will be conducted with Group as the 
independent variable and the number of  positive HVI factors as the dependent variable. 
If the effect is found to be significant, a Tukey’s posthoc analysis will be conducted. 
 
Research Question 5:  Can the mean number of aggression (AG) responses distinguish 
among Borderline Personality, Manic Bipolar, and Depressed Bipolar groups?  
Hypothesis:  The AG scores in the Borderline Personality group will be 
significantly higher than in either the Manic Bipolar or the Depressed Bipolar group. 
Proposed Analysis:  A one-way ANVOA will be conducted with Group as the 
independent variable and the number of AG responses as the dependent variable. If the 
effect is found to be significant, a Tukey’s posthoc analysis will be conducted. 
 
Research Question 6:  Can the Trauma Index distinguish among Borderline Personality, 
Manic Bipolar, and Depressed Bipolar groups?  
Hypothesis:  The Trauma Index scores in the Borderline Personality group will be 
significantly higher than in either the Manic Bipolar or the Depressed Bipolar group. 
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Proposed Analysis:  A one-way ANVOA will be conducted with Group as the 
independent variable and Trauma Index as the dependent variable. If the effect is found 
to be significant, a Tukey’s posthoc analysis will be conducted. 
 
Research Question 7:  Can the Egocentricity Index  distinguish among Borderline 
Personality, Manic Bipolar, and Depressed Bipolar groups?  
Hypothesis:  The Egocentricity Index scores in the Borderline Personality group 
will be significantly higher than in either the Manic Bipolar or the Depressed Bipolar 
group. 
Proposed Analysis:  A one-way ANVOA will be conducted with Group as the 
independent variable and the Egocentricity Index as the dependent variable. If the effect 
is found to be significant, a Tukey’s posthoc analysis will be conducted. 
 
Research Question 8:  Can the White Space (S) responses with minus form quality  
distinguish among Borderline Personality, Manic Bipolar, and Depressed Bipolar 
groups?  
Hypothesis:  The number of distorted angry responses in the Manic Bipolar group 
will be significantly higher than in either the Borderline Personality group or the 
Depressed Bipolar group. 
Proposed Analysis:  A one-way ANVOA will be conducted with Group as the 
independent variable and S-minus responses as the dependent variable. If the effect is 




Research Question 9:  Can number of positive factors in the Perceptual Thinking Index 
(PTI)  distinguish among Borderline Personality, Manic Bipolar, and Depressed Bipolar 
groups?  
Hypothesis:  The number of positive factors in the PTI in the Manic Bipolar group 
will be significantly higher than in either the Borderline Personality group or the 
Depressed Bipolar group. 
Proposed Analysis:  A one-way ANVOA will be conducted with Group as the 
independent variable and number of positive PTI factors as the dependent variable. If the 
effect is found to be significant, a Tukey’s posthoc analysis will be conducted. 
 
Research Question 10:  Can the number well-organized responses as measured by the 
number of DQ+ responses distinguish among Borderline Personality, Manic Bipolar, 
and Depressed Bipolar groups?  
Hypothesis:  The number of DQ+ responses will be significantly lower in the 
Depressed Bipolar group than in either the Borderline Personality group or the Manic 
Bipolar group. 
Proposed Analysis:  A one-way ANVOA will be conducted with Group as the 
independent variable and number of DQ+ responses as the dependent variable. If the 
effect is found to be significant, a Tukey’s posthoc analysis will be conducted. 
 
Research Question 11:  Can the number of mild lapses in ideational control as measured 
by the Level 1 Deviant Responses (DR1) distinguish among Borderline Personality, 
Manic Bipolar, and Depressed Bipolar groups?  
  
51 
Hypothesis:  The number of DR1 responses will be significantly lower in the 
Borderline Personality group than in both the Depressed Bipolar and the Manic Bipolar 
groups. 
Proposed Analysis:  A one-way ANVOA will be conducted with Group as the 
independent variable and number of DR1 responses as the dependent variable. If the 
effect is found to be significant, a Tukey’s posthoc analysis will be conducted. 
 
Research Question 12:  Can the number of more serious instances of ideational control 
as measured by Level 2 Deviant Responses (DR2) distinguish among Borderline 
Personality, Manic Bipolar, and Depressed  Bipolar groups?  
Hypothesis:  The number of DR2 responses will be significantly higher in the 
Manic Bipolar group than in both the Depressed  Bipolar and the Borderline Personality 
groups. 
Proposed Analysis:  A one-way ANVOA will be conducted with Group as the 
independent variable and number of DR1 responses as the dependent variable. If the 
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